At ASH 2015, Dr. Owen O'Connor from Columbia University discussed his abstract titled "First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)."
For more information about MPNs, please visit www.MPNUniversity.tv
![Wiózł cały motor w częściach, okazało się, że jest kradziony! [Celnicy na straży Europy]](https://i.ytimg.com/vi/82ta2RoL4pk/mqdefault.jpg)
